Tue, January 10, 2012
Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. ual-j-p-morgan-global-healthcare-conference.html
Published in Health and Fitness on Wednesday, January 4th 2012 at 13:16 GMT by Market Wire   Print publication without navigation


Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare... -- THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ --

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference

[ ]

 

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at the Westin St. Francis in San Francisco, Calif.  Robert A. Bradway, president and chief operating officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, [ www.amgen.com ], under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit [ www.amgen.com ].  Follow us on [ www.twitter.com/amgen ].

 

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])

 

 

 

 

SOURCE Amgen

[ Back to top ]

RELATED LINKS
[ http://www.amgen.com ]


Publication Contributing Sources